Arvinas

Filed a patent for "administration of cyp3a4 inducers in the treatment of cancer" on Fri, August 11, 2023

Filed a patent for "hpk1 targeting compounds and uses thereof" on Tue, August 1, 2023

Filed a patent for "dgk targeting compounds and uses thereof" on Wed, August 2, 2023

Filed a patent for "kras compounds" on Wed, July 26, 2023

Filed a patent for "combinations of estrogen receptor degraders and cdk7 inhibitors" on Tue, June 27, 2023

Filed a patent for "compounds and methods for the targeted degradation of androgen receptor" on Fri, June 30, 2023

Filed a patent for "compounds and methods for the targeted degradation of androgen receptor" on Fri, September 1, 2023

Filed a patent for "solid oral dosage forms of estrogen receptor degraders" on Mon, June 12, 2023

Filed a patent for "pharmaceutical formulations of an androgen receptor-targeting protein degrader" on Wed, January 25, 2023

Filed a patent for "dosage regimens of estrogen receptor degraders" on Tue, February 7, 2023

Filed a patent for "dosage regimens of estrogen receptor degraders" on Fri, March 24, 2023

Filed a patent for "dosage regimens of estrogen receptor degraders" on Fri, March 24, 2023

Filed a patent for "use of an androgen receptor degrader protac for the treatment of prostate cancer" on Fri, April 21, 2023

Filed a patent for "methods of treating prostate cancer with an androgen receptor degrader protac" on Tue, May 9, 2023

Filed a patent for "combinations of estrogen receptor degraders and akt inhibitors" on Fri, June 2, 2023

Filed a patent for "dosage regimens of estrogen receptor degraders" on Thu, June 15, 2023

Filed a patent for "dosage regimens of estrogen receptor degraders" on Thu, June 15, 2023

Filed a patent for "use of an androgen receptor degrader protac for the treatment of prostate cancer" on Fri, June 16, 2023

Filed a patent for "casitas b-lineage lymphoma protooncogene b (cbl-b) degrading compounds and associated methods of use" on Wed, July 19, 2023

Filed a patent for "dosage regimens of estrogen receptor degraders" on Wed, August 9, 2023

Filed a patent for "methods of treating prostate cancer with an androgen receptor degrader protac" on Thu, October 12, 2023

Filed a patent for "methods of treating prostate cancer with an androgen receptor degrader protac" on Sat, October 21, 2023

Filed a patent for "methods of treating prostate cancer with an androgen receptor degrader protac" on Fri, October 27, 2023

Filed a patent for "method of treating breast cancer" on Tue, November 28, 2023

Filed a patent for "egfr proteolysis targeting chimeric molecules and associated methods of use" on Thu, November 21, 2024